Compare Allegion PLC (ALLE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allegion PLC vs Regeneron Pharmaceuticals Inc — how do they compare? Allegion PLC trades at $168.66 (market cap $14.32B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 5.7× Allegion PLC's market cap, and Allegion PLC pays the higher dividend (1.26%). Which is the better fit depends on your goals.
| ALLE | REGN | |
|---|---|---|
Market Cap | $14.32B | $82.06B |
Sector | Industrials | Health |
52-Week High | $179.77 | $812.27 |
52-Week Low | $125.65 | $555.51 |
Enterprise Value | $16.03B | $76.77B |
Dividend Yield | 1.26% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allegion PLC
Allegion is a global security products company with a portfolio of leading brands, such as Schlage, von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2021, Allegion generated 68% of sales in the United States. The company mainly competes with Swedish-based Assa Abloy AB and Switzerland-based Dormakaba.
Read more on ALLE →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
